Need Help? Talk to an Expert +1 (408) 836-7136

Categorized Chronological Ownerhip by owner Transcripts Expert Interviews Holdings Your Highlights Financial Information Proxy/Share Holder Meeting Insider Transactions Beneficial Ownership/Institutional ownership Merger/Acquisition IPO/Public Offerings Securities-based Crowdfunding Regulation A Offering Foreign Private Issuers Mutual Funds and ETFs Variable Annuities Exhibits Delisitngs Deregister

Protalix BioTherapeutics, Inc.

CIK Ticker Name Accession Number Date Form
1006281 Protalix BioTherapeutics, Inc. 0001104659-23-062301 2023-05-18 17:00:17 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001104659-23-054819 2023-05-02 08:26:53 PRE 14A
1006281 Protalix BioTherapeutics, Inc. 0001104659-22-053664 2022-04-29 16:36:58 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001104659-22-046052 2022-04-14 16:30:26 PRE 14A
1006281 Protalix BioTherapeutics, Inc. 0001558370-21-012901 2021-09-30 16:30:44 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001558370-21-012601 2021-09-17 17:00:30 PRE 14A
1006281 Protalix BioTherapeutics, Inc. 0001558370-21-008019 2021-06-04 16:30:47 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001104659-20-046926 2020-04-15 16:30:15 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001104659-19-054172 2019-10-15 16:30:25 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-19-047387 2019-10-04 16:46:08 PRE 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-19-019545 2019-04-12 17:00:30 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-18-054229 2018-10-17 16:31:03 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-18-052765 2018-10-05 17:10:57 PRE 14A
1006281 Protalix BioTherapeutics, Inc. 0001571049-18-000157 2018-03-06 16:11:37 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-18-010571 2018-02-23 16:31:57 PRE 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-17-046387 2017-09-01 16:04:24 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-17-045196 2017-08-25 16:30:13 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-17-042072 2017-08-10 16:34:35 PRE 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-17-015102 2017-03-16 16:21:12 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-17-012961 2017-03-06 16:15:20 PRE 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-16-111273 2016-07-01 17:04:30 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-16-108563 2016-06-16 16:57:25 PRE 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-15-057696 2015-10-01 16:30:50 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-14-060401 2014-10-09 16:30:27 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-14-058440 2014-09-29 17:00:37 PRE 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-13-051645 2013-09-19 19:04:48 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-12-030772 2012-05-21 08:12:03 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-12-027203 2012-05-09 16:35:51 PRE 14A
1006281 Protalix BioTherapeutics, Inc. 0001144204-11-053749 2011-09-19 16:42:42 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0000950123-10-091152 2010-10-04 16:46:35 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0000950123-09-043950 2009-09-17 19:47:03 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0000950123-08-012018 2008-10-03 17:21:15 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0000950136-07-008573 2007-12-31 10:26:54 DEF 14A
1006281 Protalix BioTherapeutics, Inc. 0000950144-97-004419 1997-04-18 00:00:00 DEF 14A